Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer

被引：0
作者：
Shigeki Nanjo
Akito Hata
Chiyuki Okuda
Reiko Kaji
Hideaki Okada
Daisuke Tamura
Kei Irie
Hiroshi Okada
Shoji Fukushima
Nobuyuki Katakami
机构：
[1] Institute of Biomedical Research and Innovation Hospital,Division of Integrated Oncology
[2] 2-2,Department of Medical Oncology
[3] Minatojima-minamimachi,Department of Respiratory Medicine
[4] Chuo-ku,Department of Pharmacology
[5] Kobe 650-0047,Department of Pharmaceutics
[6] Japan,undefined
[7] Kobe Minimally Invasive Cancer Center,undefined
[8] Kobe 650-0046,undefined
[9] Japan,undefined
[10] Kobe University Hospital,undefined
[11] Kobe 650-0017,undefined
[12] Japan,undefined
[13] Institute of Biomedical Research and Innovation Hospital,undefined
[14] Kobe 650-0047,undefined
[15] Japan,undefined
[16] Faculty of Pharmaceutical Science,undefined
[17] Kobe Gakuin University,undefined
[18] Kobe 650-8586,undefined
[19] Japan,undefined
来源：
British Journal of Cancer | 2018年 / 118卷
关键词：
osimertinib; leptomeningeal metastases; T790M; cerebrospinal fluid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：32 / 37
页数：5
相关论文
共 50 条
  • [21] Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer
    Hui, Caressa
    Qu, Vera
    Wang, Jen-Yeu
    von Eyben, Rie
    Chang, Yu-Cheng
    Chiang, Po-Lin
    Liang, Chih-Hung
    Lu, Jen-Tang
    Li, Gordon
    Hayden-Gephart, Melanie
    Wakelee, Heather
    Neal, Joel
    Ramchandran, Kavitha
    Das, Millie
    Nagpal, Seema
    Soltys, Scott
    Myall, Nathaniel
    Pollom, Erqi
    JOURNAL OF NEURO-ONCOLOGY, 2022, 160 (01) : 233 - 240
  • [22] Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer
    Caressa Hui
    Vera Qu
    Jen-Yeu Wang
    Rie von Eyben
    Yu-Cheng Chang
    Po-Lin Chiang
    Chih-Hung Liang
    Jen-Tang Lu
    Gordon Li
    Melanie Hayden-Gephart
    Heather Wakelee
    Joel Neal
    Kavitha Ramchandran
    Millie Das
    Seema Nagpal
    Scott Soltys
    Nathaniel Myall
    Erqi Pollom
    Journal of Neuro-Oncology, 2022, 160 : 233 - 240
  • [23] ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer
    Ortega-Franco, Ana
    Rafee, Shereen
    ONCOLOGY AND THERAPY, 2022, 10 (01) : 13 - 22
  • [24] ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer
    Ana Ortega-Franco
    Shereen Rafee
    Oncology and Therapy, 2022, 10 : 13 - 22
  • [25] Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non-Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI
    Kim, Hye Ryeon
    Jo, Hyunji
    Kim, Hongsik
    Hong, Joohyun
    Park, Sehhoon
    Jung, Hyun Ae
    Lee, Se-Hoon
    Ahn, Jin-Seok
    Ahn, Myung-Ju
    CANCER RESEARCH AND TREATMENT, 2023, 55 (01): : 344 - 349
  • [26] ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial-mesenchymal transition
    Liu, Kejun
    Chen, Xianwen
    Wu, Ligang
    Chen, Shiyuan
    Fang, Nianxin
    Cai, Limin
    Jia, Jun
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [27] Impact of apatinib in combination with osimertinib on EGFR T790M-positive lung adenocarcinoma
    Liu, Yang
    Xiong, Zhi-Cheng
    Sun, Xin
    Sun, Li
    Zhang, Shu-Ling
    Ma, Jie-Tao
    Han, Cheng-Bo
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 2151 - 2163
  • [28] EGFR-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine: Importance of Germline EGFR T790M Testing
    Sukari, Ammar
    Nagasaka, Misako
    Wakeling, Erin
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (10): : 1188 - 1192
  • [29] Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer
    Tozuka, Takehiro
    Noro, Rintaro
    Mizutani, Hideaki
    Kurimoto, Futoshi
    Hakozaki, Taiki
    Hisakane, Kakeru
    Naito, Tomoyuki
    Takahashi, Satoshi
    Taniuchi, Namiko
    Yajima, Chika
    Hosomi, Yukio
    Hirose, Takashi
    Minegishi, Yuji
    Okano, Tetsuya
    Kamio, Koichiro
    Yamaguchi, Tomoyoshi
    Seike, Masahiro
    LUNG CANCER, 2024, 191
  • [30] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
    Gen, Soei
    Tanaka, Ichidai
    Morise, Masahiro
    Koyama, Junji
    Kodama, Yuta
    Matsui, Akira
    Miyazawa, Ayako
    Hase, Tetsunari
    Hibino, Yoshitaka
    Yokoyama, Toshihiko
    Kimura, Tomoki
    Yoshida, Norio
    Sato, Mitsuo
    Hashimoto, Naozumi
    BMC CANCER, 2022, 22 (01)
12345